(Q44393974)

English

Decreasing levels of tumour necrosis factor alpha and interleukin 6 during lowering of body mass index with orlistat or placebo in obese subjects with cardiovascular risk factors

scientific article published in May 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 December 2017

Decreasing levels of tumour necrosis factor alpha and interleukin 6 during lowering of body mass index with orlistat or placebo in obese subjects with cardiovascular risk factors (English)

1 reference

Europe PubMed Central

2 December 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

circulatory system

1 reference

based on heuristic

inferred from title

author name string

Samuelsson L

1

1 reference

Europe PubMed Central

2 December 2017

Gottsäter A

2

1 reference

Europe PubMed Central

2 December 2017

Lindgärde F

3

1 reference

Europe PubMed Central

2 December 2017

publication date

1 May 2003

1 reference

Europe PubMed Central

2 December 2017

Diabetes, Obesity and Metabolism

1 reference

Europe PubMed Central

2 December 2017

5

1 reference

Europe PubMed Central

2 December 2017

195-201

1 reference

Europe PubMed Central

2 December 2017

3

1 reference

Europe PubMed Central

2 December 2017

Effects of sibutramine on body weight and serum lipids: a double-blind, randomized, placebo-controlled study in 322 overweight and obese patients with dyslipidemia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00264.X

21 January 2018

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00264.X

21 January 2018

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00264.X

21 January 2018

Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00264.X

21 January 2018

Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00264.X

21 January 2018

In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00264.X

21 January 2018

In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00264.X

21 January 2018

Isoprostanes: potential markers of oxidant stress in atherothrombotic disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00264.X

21 January 2018

F2-isoprostane evidence of oxidant stress in the insulin resistant, obese Zucker rat: effects of vitamin E.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00264.X

21 January 2018

Oxidative stress in a rat model of obesity-induced hypertension.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00264.X

21 January 2018

Long-term pharmacotherapy of obesity 2000: a review of efficacy and safety

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00264.X

21 January 2018

The effect of orlistat on body weight and coronary heart disease risk profile in obese patients: the Swedish Multimorbidity Study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00264.X

21 January 2018

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00264.X

21 January 2018

Elevated Levels of Interleukin 6 Are Reduced in Serum and Subcutaneous Adipose Tissue of Obese Women after Weight Loss

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00264.X

21 January 2018

Elevated C-reactive protein levels in overweight and obese adults

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2003.00264.X

21 January 2018

Identifiers

10.1046/J.1463-1326.2003.00264.X

1 reference

Europe PubMed Central

2 December 2017

1 reference

Europe PubMed Central

2 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44393974&oldid=2020950441"